These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4082288)

  • 1. In vitro activity of alkylating agents on human tumors as measured by a short-term antimetabolic assay.
    Zaffaroni N; Silvestrini R; Sanfilippo O; Daidone MG; Gasparini G
    Tumori; 1985 Dec; 71(6):555-61. PubMed ID: 4082288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of an in vitro antimetabolic assay to human germ cell testicular tumors for the preclinical evaluation of drug sensitivity.
    Sanfilippo O; Silvestrini R; Zaffaroni N; Piva L; Pizzocaro G
    Cancer; 1986 Oct; 58(7):1441-7. PubMed ID: 3017538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of an in vitro short-term assay to predict the drug sensitivity of human breast cancer.
    Daidone MG; Silvestrini R; Sanfilippo O; Zaffaroni N; Varini M; De Lena M
    Cancer; 1985 Aug; 56(3):450-6. PubMed ID: 4039971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug sensitivity of different tumor lesions from the same patient evaluated by a short-term assay.
    Zaffaroni N; Silvestrini R; Sanfilippo O; Daidone MG; Bolis G; Seminara P
    Tumori; 1988 Apr; 74(2):137-44. PubMed ID: 3368967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative test for chemosensitivity of short-term cultures of human lymphomas.
    Costa A; Piazza R; Sanfilippo O; Silvestrini R
    Tumori; 1977; 63(3):237-47. PubMed ID: 898291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anthracycline in colorectal carcinoma: an in vitro short-term assay to predict drug sensitivity. Preliminary results.
    Seminara P; Franchi F; Mulieri M; D'Amelio R; Codacci Pisanelli G; Aronne T; Manfredi D
    Tumori; 1987 Feb; 73(1):69-73. PubMed ID: 3469807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic cytotoxicity of different alkylating agents for epithelial ovarian cancer.
    Lidor YJ; Shpall EJ; Peters WP; Bast RC
    Int J Cancer; 1991 Nov; 49(5):704-10. PubMed ID: 1937956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative autoradiographic in vitro study of the incorporation of 3H-thymidine and 3H-uridine into the DNA and RNA of solid tumours in children.
    Willnow U
    Arch Geschwulstforsch; 1980; 50(8):778-84. PubMed ID: 7224820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemosensitivity testing of ovarian cancer: results of a rapid in vitro biochemical assay.
    Khoo SK; Hurst T; Webb MJ
    Aust N Z J Obstet Gynaecol; 1985 Aug; 25(3):215-20. PubMed ID: 3866561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical studies and clinical correlation of the effect of alkylating dose.
    Frei E; Teicher BA; Holden SA; Cathcart KN; Wang YY
    Cancer Res; 1988 Nov; 48(22):6417-23. PubMed ID: 3180059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide.
    Zalupski M; Baker LH
    J Natl Cancer Inst; 1988 Jun; 80(8):556-66. PubMed ID: 3286879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The present status of cancer chemotherapy.
    Krakoff IH
    Med Clin North Am; 1971 May; 55(3):683-701. PubMed ID: 4102661
    [No Abstract]   [Full Text] [Related]  

  • 13. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
    Kelland LR; Mistry P; Abel G; Freidlos F; Loh SY; Roberts JJ; Harrap KR
    Cancer Res; 1992 Apr; 52(7):1710-6. PubMed ID: 1312897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy tested in a short-term thymidine incorporation assay in primary cultures of ovarian adenocarcinomas.
    Hayward IP; Hurst T; Parsons PG; Khoo SK
    Int J Cell Cloning; 1992 May; 10(3):182-9. PubMed ID: 1613269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absolute and relative activities of platinum-complexes on human tumors as evaluated by an antimetabolic in vitro assay.
    Daidone MG; Silvestrini R; Zaffaroni N; Grignolio E; Landoni F
    Invest New Drugs; 1987; 5(3):245-50. PubMed ID: 3312080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [On the problem of praetherapeutic sensitivity testing of human tumours based on incorporation studies of nucleic acid precursors in vitro (author's transl)].
    Seeber S; Schmidt CG
    Klin Wochenschr; 1977 Dec; 55(23):1127-36. PubMed ID: 340776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of in vitro drug sensitivity testing based on short-term effects on DNA and RNA metabolism in ovarian cancer.
    Khoo SK; Hurst T; Webb MJ; Dickie G; Kearsley J; Parsons PG; Mackay EV
    J Surg Oncol; 1989 Jul; 41(3):201-5. PubMed ID: 2747246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
    Wilson AP; Neal FE
    Br J Cancer; 1981 Aug; 44(2):189-200. PubMed ID: 6791675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pretherapeutic cytostatic agent sensitivity testing of breast cancer].
    Schlag P; Geier G; Veser J; Breitig D; Betzler M; Herfarth C
    Chir Forum Exp Klin Forsch; 1978; (1978):231-4. PubMed ID: 752591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractional incorporation of radionucleotides, a marker of in vitro tumor cell chemosensitivity in colorectal cancer.
    Franchi F; Seminara P; Giannarelli D; Konovalova N
    Oncology; 1991; 48(6):510-6. PubMed ID: 1749592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.